Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns ...Middle East

By Meg Tirrell, CNN (CNN) — Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief executive of Ozempic maker Novo Nordisk warned Wednesday. “Honestly, I’m quite alarmed by what we see in the US now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN. “Patients who believe that they’re getting access to a safe product, and they believe they’re getting semaglutide … I know for a fact that they are not getting semaglutide, because there’s only one semaglutide, and that’s produced by Novo Nordisk, and we don’t sell that to others.”

Hence then, the article about compounded semaglutide associated with at least 10 deaths novo nordisk ceo warns was published today ( Wednesday 06/11/2024 - 10:29 PM ) and is available on News channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns )

Also on site :

• Texas Roadhouse & Olive Garden among restaurants mandating strict ‘one ring’ policy for diner safety
• Alec Baldwin hits back at Elon Musk for criticizing Lupita Nyong’o’s looks amid ‘The Odyssey’ casting
• 90 minutos para el infarto: todo lo que se define en la última jornada de las ligas de España, Inglaterra e Italia